Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Osteosarcoma × Doxorubicin × Clear all

Status

Sponsor Class

Study Type

Interventional 21 Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Lymphoma 2 Cardiotoxicity 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Pseudomyxoma Peritonei 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neurotoxicity Syndromes 1 Neoplasm, Residual 1 Mesothelioma 1 Lymphoma, Follicular 1 Fatigue 1 Fallopian Tube Neoplasms 1 Desmoid Tumors 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Breast Cancer Organoids 1 Appendiceal Neoplasms 1

Interventions

mifamurtide 2 Surveys and Questionnaires 2 Methotrexate 2 Drug Therapy 2 Blood Specimen Collection 2 glucarpidase 1 Weight-Bearing 1 Tomography, X-Ray Computed 1 Therapeutics 1 Reverse Transcriptase Polymerase Chain Reaction 1 Range of Motion, Articular 1 Psychiatric Rehabilitation 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Microarray Analysis 1 Magnetic Resonance Imaging 1 In Situ Hybridization, Fluorescence 1 HMPL-013 1 Gene Rearrangement 1 Gene Expression Profiling 1 Doxorubicin 1 Clinical Protocols 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02986503 2016-12-08

EUROBOSS

Italian Sarcoma Group

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡